IS7300A - Notkun anastrósóls til að meðhöndla konur eftir tíðahvörf sem eru með brjóstakrabbamein á frumstigi - Google Patents

Notkun anastrósóls til að meðhöndla konur eftir tíðahvörf sem eru með brjóstakrabbamein á frumstigi

Info

Publication number
IS7300A
IS7300A IS7300A IS7300A IS7300A IS 7300 A IS7300 A IS 7300A IS 7300 A IS7300 A IS 7300A IS 7300 A IS7300 A IS 7300A IS 7300 A IS7300 A IS 7300A
Authority
IS
Iceland
Prior art keywords
breast cancer
anastrozole
early
postmenopausal women
stage breast
Prior art date
Application number
IS7300A
Other languages
English (en)
Inventor
Plourde Paul
Rogers Anthony
Vose Brent
Dukes Michael
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9927290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS7300(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS7300A publication Critical patent/IS7300A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Chemical Treatment Of Metals (AREA)
IS7300A 2001-12-10 2004-06-04 Notkun anastrósóls til að meðhöndla konur eftir tíðahvörf sem eru með brjóstakrabbamein á frumstigi IS7300A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0129457.8A GB0129457D0 (en) 2001-12-10 2001-12-10 Method of treatment
PCT/GB2002/005554 WO2003053438A1 (en) 2001-12-10 2002-12-06 Use of anastrozole for the treatment of post-menopausal women having early breast cancer

Publications (1)

Publication Number Publication Date
IS7300A true IS7300A (is) 2004-06-04

Family

ID=9927290

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7300A IS7300A (is) 2001-12-10 2004-06-04 Notkun anastrósóls til að meðhöndla konur eftir tíðahvörf sem eru með brjóstakrabbamein á frumstigi

Country Status (29)

Country Link
US (1) US20050165081A1 (is)
EP (2) EP1455781B1 (is)
JP (2) JP5335173B2 (is)
KR (1) KR100858946B1 (is)
CN (1) CN100408036C (is)
AT (1) ATE406160T1 (is)
AU (1) AU2002347371B2 (is)
BR (1) BR0214798A (is)
CA (1) CA2468965C (is)
CO (1) CO5590926A2 (is)
CY (1) CY1108462T1 (is)
DE (1) DE60228616D1 (is)
DK (1) DK1455781T3 (is)
ES (1) ES2303811T3 (is)
GB (1) GB0129457D0 (is)
HK (1) HK1069335A1 (is)
HU (1) HUP0402023A3 (is)
IL (1) IL162150A0 (is)
IS (1) IS7300A (is)
MX (1) MXPA04005394A (is)
NO (1) NO20042912L (is)
NZ (1) NZ533106A (is)
PL (1) PL369411A1 (is)
PT (1) PT1455781E (is)
RU (1) RU2320339C2 (is)
SI (1) SI1455781T1 (is)
UA (1) UA79443C2 (is)
WO (1) WO2003053438A1 (is)
ZA (1) ZA200404260B (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0129457D0 (en) * 2001-12-10 2002-01-30 Astrazeneca Ab Method of treatment
WO2005089511A2 (en) * 2004-03-19 2005-09-29 Transform Pharmaceuticals, Inc. Novel pharmaceutical forms, and methods of making and using the same
WO2005117864A1 (en) * 2004-05-28 2005-12-15 Astrazeneca Ab Combination product comprising anastrozole and a dual prenyl transferase inhibitor
CN100337625C (zh) * 2004-08-30 2007-09-19 鲁南制药集团股份有限公司 阿那曲唑的分散片剂型
CN1304054C (zh) * 2004-12-29 2007-03-14 山东蓝金生物工程有限公司 一种缓慢释放的抗癌药物组合物
GB0517674D0 (en) * 2005-08-31 2005-10-05 Astrazeneca Ab Formulation
GB0517673D0 (en) * 2005-08-31 2005-10-05 Astrazeneca Ab Formulation
WO2011130381A1 (en) * 2010-04-13 2011-10-20 Estrocept Diagnostics, Inc. Diagnostic assays for breast cancer treatment and progression
US10201549B2 (en) 2013-06-14 2019-02-12 Professional Compounding Centers Of America (Pcca) Testosterone combined with anastrozole injection solutions
CN103450099B (zh) * 2013-09-06 2015-03-25 杭州华东医药集团新药研究院有限公司 阿那曲唑及其一水合物的新晶型、制备和用途
RU2548722C1 (ru) * 2013-12-06 2015-04-20 Федеральное государственное бюджетное учреждение "Национальный исследовательский центр "Курчатовский институт" Противоопухолевое лекарственное средство пролонгированного действия на основе противоопухолевого препарата, ингибитора синтеза эстрогенов - анастрозола
DE102014005513B4 (de) * 2014-04-15 2018-03-15 Sanoxsys Gmbh Mittel zur Prävention und Therapie von Tumorerkrankungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714013D0 (en) * 1987-06-16 1987-07-22 Ici Plc (substituted-aralkyl)heterocyclic compounds
AR034142A1 (es) * 2000-09-08 2004-02-04 Sloan Kettering Inst Cancer Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
GB0129457D0 (en) * 2001-12-10 2002-01-30 Astrazeneca Ab Method of treatment

Also Published As

Publication number Publication date
EP1455781A1 (en) 2004-09-15
KR20040066886A (ko) 2004-07-27
CY1108462T1 (el) 2014-04-09
HUP0402023A2 (hu) 2005-01-28
DE60228616D1 (de) 2008-10-09
SI1455781T1 (sl) 2008-12-31
CA2468965A1 (en) 2003-07-03
RU2004121162A (ru) 2005-05-20
PL369411A1 (en) 2005-04-18
RU2320339C2 (ru) 2008-03-27
AU2002347371B2 (en) 2007-05-10
MXPA04005394A (es) 2005-04-19
BR0214798A (pt) 2004-10-19
CN100408036C (zh) 2008-08-06
UA79443C2 (en) 2007-06-25
HUP0402023A3 (en) 2008-08-28
EP1997492A1 (en) 2008-12-03
CA2468965C (en) 2011-08-30
ES2303811T1 (es) 2008-09-01
JP2011016828A (ja) 2011-01-27
GB0129457D0 (en) 2002-01-30
EP1455781B1 (en) 2008-08-27
JP2005516021A (ja) 2005-06-02
NO20042912L (no) 2004-08-25
ES2303811T3 (es) 2009-02-01
ATE406160T1 (de) 2008-09-15
IL162150A0 (en) 2005-11-20
NZ533106A (en) 2008-02-29
KR100858946B1 (ko) 2008-09-17
CN1630519A (zh) 2005-06-22
HK1069335A1 (en) 2005-05-20
DK1455781T3 (da) 2008-11-24
AU2002347371A1 (en) 2003-07-09
PT1455781E (pt) 2008-11-03
JP5335173B2 (ja) 2013-11-06
WO2003053438A1 (en) 2003-07-03
ZA200404260B (en) 2005-10-26
US20050165081A1 (en) 2005-07-28
CO5590926A2 (es) 2005-12-30

Similar Documents

Publication Publication Date Title
HK1069335A1 (en) Use of anastrozole for the treatment of post-menopausal women having early breast cancer
MY127290A (en) New use of flibanserin
ZA200305126B (en) Methods of administering epothilone analogs for the treatment of cancer.
BG108495A (en) 5-ht receptor ligands and uses thereof
EA200101046A1 (ru) Производные индигоидных бис-индолов
DK1482948T3 (da) Kontinuerlig sulfataseinhiberende progestogen-hormonsubstitutionsbehandling
MXPA04003087A (es) Derivados de cromano como ligados de 5-hidroxitriptamina-6.
HUP0301460A2 (hu) Antiprogresztinek használata hormonfüggő betegségek megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállításához
GR970100409A (el) Βελτιωσεις στην προληψη του καρκινου του μαστου και σε σχεση με αυτην
MXPA04004306A (es) Uso de antagonistas del receptor de endotelina para el tratamiento de enfermedades tumorales.
MXPA05006981A (es) Derivados de prostaglandinas para el tratamiento de la molestia abdominal.
BR0311146A (pt) Uso de tibolona e de modulador de receptor de estrogênio seletivo, e, método e kit para o tratamento de um sintoma relacionado com a deficiência de estrogênio em um paciente do sexo feminino
HUP0500346A2 (hu) Konjugált ösztrogének alkalmazása ösztrogénpótó terápiában hatásos gyógyszerkészítmények előállítására
EA200200943A1 (ru) Гормональная терапия рака молочной железы
AR025718A1 (es) Metodo para reducir el riesgo de cancer
WO2002020000A3 (en) Combined estrogen blockade of the breast with exemestane and raloxifene
CA2481602A1 (en) Pharmaceutical composition comprising arsenite for the treatment of malignancy
HUP0301276A2 (hu) Kombinációs terápia ösztrogénérzékeny betegségek kezelésére
RS16804A (en) Use of 4-pyridylmethylphthalazines for cancer treatment
DE69912477D1 (de) Endokrintherapie für brustkrebs: kombinierte behandlung mit tamoxifen und alkyl-pcdfs
DK1326617T3 (da) Anvendelse af 11beta- (acetylphenyl) -17beta-hydroxy-17alfa- (1,1,2,2-pentafluorethyl) estra-4,9-dien-3-on til fremstilling af et medikament til behandling af brystcancer, ovariecancer, endometrisk caner, myeloma og meningeom
YU29903A (sh) Upotreba antiprogestina za indukciju apoptoze u ćeliji
EP1147208A4 (en) COMPOSITIONS AND METHODS FOR INTRADUCTAL GENE THERAPY
TW200605891A (en) Use of 7-t-butoxyiminomethylcamptothecin for the preparation of a medicament for the treatment of uterine neoplasms
ATE263164T1 (de) Bentzothiophene